Citadel Advisors’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.7M Buy
614,814
+166,114
+37% +$6.11M ﹤0.01% 2360
2025
Q4
$17.2M Buy
448,700
+74,665
+20% +$1.64M ﹤0.01% 2536
2025
Q3
$5.14M Buy
374,035
+19,572
+6% +$230K ﹤0.01% 4314
2025
Q2
$4.58M Buy
354,463
+293,393
+480% +$3.05M ﹤0.01% 4266
2025
Q1
$686K Sell
61,070
-158,808
-72% -$2.08M ﹤0.01% 7787
2024
Q4
$2.88M Buy
219,878
+57,265
+35% +$1.47M ﹤0.01% 4905
2024
Q3
$6.5M Sell
162,613
-690,163
-81% -$25.1M ﹤0.01% 3529
2024
Q2
$25.2M Buy
+852,776
New +$23.2M 0.01% 1764

Other funds holding PACS

Citadel Advisors's PACS Position: Q1 2026 in Review

Citadel Advisors increased its PACS Group (PACS) stake by 37% in Q1 2026, buying an estimated $6.11M and bringing the position to 614,814 shares worth $19.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2360.

Citadel Advisors first reported a position in PACS in Q2 2024 and has held it in 8 quarters since. The position peaked at $25.2M in Q2 2024. 215 funds tracked by Wall St. Rank hold PACS as of Q1 2026.

  • Citadel Advisors held 614,814 shares of PACS Group worth $19.7M as of Q1 2026.
  • Citadel Advisors bought 166,114 PACS Group shares in Q1 2026, an estimated $6.11M.
  • PACS Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2360 holding.
  • Citadel Advisors first reported a position in PACS Group in Q2 2024 and has held it in 8 quarters since.
  • Citadel Advisors's PACS Group position peaked at $25.2M in Q2 2024.
  • 215 funds tracked by Wall St. Rank held PACS Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.